These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34042038)

  • 41. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
    Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
    Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Smart Nanotherapeutic Targeting of Tumor Vasculature.
    Li Z; Di C; Li S; Yang X; Nie G
    Acc Chem Res; 2019 Sep; 52(9):2703-2712. PubMed ID: 31433171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanorobot: a versatile tool in nanomedicine.
    Patel GM; Patel GC; Patel RB; Patel JK; Patel M
    J Drug Target; 2006 Feb; 14(2):63-7. PubMed ID: 16608733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Application of nanotechnology in cancer therapy and imaging.
    Wang X; Yang L; Chen ZG; Shin DM
    CA Cancer J Clin; 2008; 58(2):97-110. PubMed ID: 18227410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic review: the applications of nanotechnology in gastroenterology.
    Brakmane G; Winslet M; Seifalian AM
    Aliment Pharmacol Ther; 2012 Aug; 36(3):213-21. PubMed ID: 22686286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.
    Garg T; Bhandari S; Rath G; Goyal AK
    J Drug Target; 2015 Dec; 23(10):865-87. PubMed ID: 25835469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nano-enabled delivery systems across the blood-brain barrier.
    Hwang SR; Kim K
    Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New perspectives of nanoneuroprotection, nanoneuropharmacology and nanoneurotoxicity: modulatory role of amino acid neurotransmitters, stress, trauma, and co-morbidity factors in nanomedicine.
    Sharma HS; Sharma A
    Amino Acids; 2013 Nov; 45(5):1055-71. PubMed ID: 24022705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Self-assembled Nucleic Acid Nanostructures for Cancer Theranostic Medicines.
    Fu J; Stankeviciute G; Oh SW; Collins J; Zhong Y; Zhang T
    Curr Top Med Chem; 2017; 17(16):1815-1828. PubMed ID: 27875979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liposomes and nanotechnology in drug development: focus on neurological targets.
    Ramos-Cabrer P; Campos F
    Int J Nanomedicine; 2013; 8():951-60. PubMed ID: 23486739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Micro and nanorobot-based drug delivery: an overview.
    Suhail M; Khan A; Rahim MA; Naeem A; Fahad M; Badshah SF; Jabar A; Janakiraman AK
    J Drug Target; 2022 Apr; 30(4):349-358. PubMed ID: 34706620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted Drug Delivery in Brain Tumors-nanochemistry Applications and Advances.
    Ganjeifar B; Morshed SF
    Curr Top Med Chem; 2021 Oct; 21(14):1202-1223. PubMed ID: 33185163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoparticles: Novel vehicles in treatment of Glioblastoma.
    Pourgholi F; Hajivalili M; Farhad JN; Kafil HS; Yousefi M
    Biomed Pharmacother; 2016 Feb; 77():98-107. PubMed ID: 26796272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
    Hassanzadeh P; Atyabi F; Dinarvand R
    Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug delivery approaches for the treatment of glioblastoma multiforme.
    Fakhoury M
    Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1365-73. PubMed ID: 26046399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Intelligent DNA Nanorobot with
    Ma W; Zhan Y; Zhang Y; Shao X; Xie X; Mao C; Cui W; Li Q; Shi J; Li J; Fan C; Lin Y
    Nano Lett; 2019 Jul; 19(7):4505-4517. PubMed ID: 31185573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.